Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Factors Associated With an Electronic Health Record-Based Definition of Postacute Sequelae of COVID-19 in Patients With Systemic Autoimmune Rheumatic Disease.
Patel NJ, Wang X, Lin M, Kowalski EN, Cook CE, Vanni KMM, Guzzo K, Qian G, Bade KJ, Saavedra A, Venkat R, Srivatsan S, Williams ZK, Hanberg JS, Kawano Y, Schiff AE, Sparks JA, Wallace ZS. Patel NJ, et al. Among authors: kowalski en. J Rheumatol. 2024 May 1;51(5):529-537. doi: 10.3899/jrheum.2023-1092. J Rheumatol. 2024. PMID: 38428964 Free article.
Effectiveness of a fourth dose of COVID-19 mRNA vaccine in patients with systemic autoimmune rheumatic diseases using disease-modifying antirheumatic drugs: an emulated target trial.
Hanberg JS, Fu X, Wang X, Patel NJ, Kawano Y, Schiff A, Kowalski EN, Cook CE, Vanni KMM, Guzzo K, Qian G, Bade KJ, Saavedra A, Venkat R, Srivatsan S, Zhang Y, Sparks JA, Wallace ZS. Hanberg JS, et al. Among authors: kowalski en. Lancet Rheumatol. 2024 Jan;6(1):e21-e30. doi: 10.1016/S2665-9913(23)00272-2. Epub 2023 Nov 15. Lancet Rheumatol. 2024. PMID: 38258675 Clinical Trial.
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study.
Schiff AE, Wang X, Patel NJ, Kawano Y, Hanberg JL, Kowalski EN, Cook CE, Vanni KM, Qian G, Bade KJ, Saavedra AA, Srivatsan S, Williams ZK, Venkat RK, Wallace ZS, Sparks JA. Schiff AE, et al. Among authors: kowalski en. Ann Rheum Dis. 2024 Apr 11;83(5):680-682. doi: 10.1136/ard-2023-225162. Ann Rheum Dis. 2024. PMID: 38199795 No abstract available.
Immunomodulator use, risk factors and management of flares, and mortality for patients with pre-existing rheumatoid arthritis after immune checkpoint inhibitors for cancer.
McCarter KR, Arabelovic S, Wang X, Wolfgang T, Yoshida K, Qian G, Kowalski EN, Vanni KMM, LeBoeuf NR, Buchbinder EI, Gedmintas L, MacFarlane LA, Rao DA, Shadick NA, Gravallese EM, Sparks JA. McCarter KR, et al. Among authors: kowalski en. Semin Arthritis Rheum. 2024 Feb;64:152335. doi: 10.1016/j.semarthrit.2023.152335. Epub 2023 Dec 8. Semin Arthritis Rheum. 2024. PMID: 38100899
Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases: a prospective study.
Venkat RK, Wang X, Patel NJ, Kawano Y, Schiff A, Kowalski EN, Cook CE, Vanni KMM, Qian G, Bade KJ, Saavedra A, Srivatsan S, Williams ZK, Wallace ZS, Sparks JA. Venkat RK, et al. Among authors: kowalski en. Rheumatology (Oxford). 2023 Dec 9:kead662. doi: 10.1093/rheumatology/kead662. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 38070152
239 results